178 related articles for article (PubMed ID: 24806822)
1. Novel simvastatin inhalation formulation and characterisation.
Tulbah AS; Ong HX; Colombo P; Young PM; Traini D
AAPS PharmSciTech; 2014 Aug; 15(4):956-62. PubMed ID: 24806822
[TBL] [Abstract][Full Text] [Related]
2. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
3. The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler.
Saadat A; Zhu B; Haghi M; King G; Colombo G; Young PM; Traini D
J Pharm Pharmacol; 2014 May; 66(5):639-45. PubMed ID: 24329164
[TBL] [Abstract][Full Text] [Related]
4. Application of co-grinding to formulate a model pMDI suspension.
Williams RO; Repka MA; Barron MK
Eur J Pharm Biopharm; 1999 Sep; 48(2):131-40. PubMed ID: 10469931
[TBL] [Abstract][Full Text] [Related]
5. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
Zhu B; Haghi M; Goud M; Young PM; Traini D
Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
[TBL] [Abstract][Full Text] [Related]
6. Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons.
Tulbah AS; Ong HX; Colombo P; Young PM; Traini D
Expert Opin Drug Deliv; 2016 Oct; 13(10):1407-20. PubMed ID: 27212150
[TBL] [Abstract][Full Text] [Related]
7. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
8. Dry powder formulation of simvastatin.
Tulbah AS; Ong HX; Morgan L; Colombo P; Young PM; Traini D
Expert Opin Drug Deliv; 2015 Jun; 12(6):857-68. PubMed ID: 25244365
[TBL] [Abstract][Full Text] [Related]
9. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
10. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
Lu W; Rades T; Rantanen J; Chan HK; Yang M
Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
[TBL] [Abstract][Full Text] [Related]
11. Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells.
Tulbah AS; Ong HX; Lee WH; Colombo P; Young PM; Traini D
Pharm Res; 2016 Jan; 33(1):92-101. PubMed ID: 26238046
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers.
Haynes A; Shaik MS; Krarup H; Singh M
J Pharm Sci; 2004 Feb; 93(2):349-63. PubMed ID: 14705192
[TBL] [Abstract][Full Text] [Related]
13. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
Yu J; Chan HK; Gengenbach T; Denman JA
Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
[TBL] [Abstract][Full Text] [Related]
14. The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent.
Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
AAPS PharmSciTech; 2009; 10(1):252-7. PubMed ID: 19291411
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
16. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
17. Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulation.
Williams RO; Brown J; Liu J
Pharm Dev Technol; 1999 May; 4(2):167-79. PubMed ID: 10231878
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of the OptiChamber Diamond valved holding chamber.
Hatley RH; von Hollen D; Sandell D; Slator L
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
[TBL] [Abstract][Full Text] [Related]
19. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]